Genome editing and stem cell therapy pave the path for new treatment of sickle-cell disease

Por Randolph, Mary Katherine, Zhao, Wanke
Publicado no Stem Cell Investig (2015)

Quantitative analyses of myelofibrosis by determining hydroxyproline

Por Zhao, Wanke, Ho, Wan-Ting Tina, Zhao, Zhizhuang Joe
Publicado no Stem Cell Investig (2015)

Generation of a New Congenic Mouse Strain with Enhanced Chymase Expression in Mast Cells

Por Jin, Xi, Zhao, Wanke, Shi, Kaiyao, Ho, Wanting T., Zhao, Zhizhuang J.
Publicado em 2013

Myotubularin family phosphatase ceMTM3 is required for muscle maintenance by preventing excessive autophagy in <it>Caenorhabditis elegans</it>

Por Yu Xiaokun, Ma Junfeng, Lin Feng, Zhao Wanke, Fu Xueqi, Zhao Zhizhuang
Publicado em 2012-10-01

JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines

Por Zhao, Wanke, Du, Yanhong, Ho, Wanting Tina, Fu, Xueqi, Zhao, Zhizhuang Joe
Publicado em 2012

Generation and Characterization of a JAK2V617F-Containing Erythroleukemia Cell Line

Por Zhao, Wanke, Zou, Kang, Farasyn, Taleah, Ho, Wanting Tina, Zhao, Zhizhuang Joe
Publicado em 2014

Myotubularin family phosphatase ceMTM3 is required for muscle maintenance by preventing excessive autophagy in Caenorhabditis elegans

Por Yu, Xiaokun, Ma, Junfeng, Lin, Feng, Zhao, Wanke, Fu, Xueqi, Zhao, Zhizhuang Joe
Publicado em 2012

Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice

Por Shi, Kaiyao, Zhao, Wanke, Chen, Yun, Ho, Wanting Tina, Yang, Ping, Zhao, Zhizhuang Joe
Publicado em 2014

Identification of an orally available compound with potent and broad FLT3 inhibition activity

Por Chen, Yun, Guo, Yao, Zhao, Wanke, Tina Ho, Wan-Ting, Fu, Xueqi, Joe Zhao, Zhizhuang
Publicado no Oncogene (2015)

Stem and Progenitor Cell Subsets Are Affected by JAK2 Signaling and Can Be Monitored by Flow Cytometry

Por Iida, Ryuji, Welner, Robert S., Zhao, Wanke, Alberola-lla, José, Medina, Kay L., Zhao, Zhizhuang Joe, Kincade, Paul W.
Publicado em 2014

Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia

Por Chen, Yun, Pan, Yihang, Guo, Yao, Zhao, Wanke, Ho, Wanting Tina, Wang, Jianlong, Xu, Mingjiang, Yang, Feng-Chun, Zhao, Zhizhuang Joe
Publicado no Stem Cell Investig (2017)

Efficacy of ALK5 inhibition in myelofibrosis

Por Yue, Lanzhu, Bartenstein, Matthias, Zhao, Wanke, Ho, Wanting Tina, Han, Ying, Murdun, Cem, Mailloux, Adam W., Zhang, Ling, Wang, Xuefeng, Budhathoki, Anjali, Pradhan, Kith, Rapaport, Franck, Wang, Huaquan, Shao, Zonghong, Ren, Xiubao, Steidl, Ulrich, Levine, Ross L., Zhao, Zhizhuang Joe, Verma, Amit, Epling-Burnette, Pearlie K.
Publicado no JCI Insight (2017)

Phenotype risk scores identify patients with unrecognized Mendelian disease patterns

Por Bastarache, Lisa, Hughey, Jacob J., Hebbring, Scott, Marlo, Joy, Zhao, Wanke, Ho, Wanting T., Van Driest, Sara L., McGregor, Tracy L., Mosley, Jonathan D., Wells, Quinn S., Temple, Michael, Ramirez, Andrea H., Carroll, Robert, Osterman, Travis, Edwards, Todd, Ruderfer, Douglas, Velez Edwards, Digna R., Hamid, Rizwan, Cogan, Joy, Glazer, Andrew, Wei, Wei-Qi, Feng, QiPing, Brilliant, Murray, Zhao, Zhizhuang J., Cox, Nancy J., Roden, Dan M., Denny, Joshua C.
Publicado no Science (2018)